Secretoneurin facilitates endothelium-dependent relaxations in porcine coronary arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Chan, Calvin K Y ^a   Vanhoutte, Paul M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Chonbuk National University   (South Korea)

Author keywords

Nitric oxide; Secretogranin ii

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; CALCIMYCIN; CALMIDAZOLIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; SECRETONEURIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CORONARY ARTERY; DIMERIZATION; ENDOTHELIUM DEPENDENT RELAXATION; GENE EXPRESSION; HYPERPOLARIZATION; IMMUNOBLOTTING; INCUBATION TIME; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE; UPREGULATION; VASODILATATION;

EID: 79955060175     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00519.2010     Document Type: Article

References (37)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
2. Alvarado-Vasquez N, Zapata E, Alcazar-Leyva S, Masso F, Montano LF. Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes. Diabetes Metab Res Rev 23: 559-566, 2007.
3. Coleman RA, Humphrey PP, Kennedy I, Levy GP, Lumley P. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73: 773-778, 1981.
4. Félétou M, Vanhoutte PM. EDHF: The Complete Story. Boca Raton: CRC/Taylor & Francis Group, 2006.
5. Fischer-Colbrie R, Kirchmair R, Kahler CM, Wiedermann CJ, Saria A. Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. Curr Protein Pept Sci 6: 373-385, 2005.
6. Flavahan NA, Vanhoutte PM. G-proteins and endothelial responses. Blood Vessels 27: 218-229, 1990.
7. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 43: 532-541, 1999.
8. Furchgott RF, Zawadzki JV. The obilgatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
9. Gruber B, Schratzberger P, Kahler CM, Dunzendorfer S, Bellmann R, Reinisch N, Wiedermann CJ. Staurosporine-dependent activation of human endothelial cell monolayers for neutrophil adherence by secreto-neurin. Peptides 18: 1445-1447, 1997.
10. Hutcheson IR, Chaytor AT, Evans WH, Griffith TM. Nitric oxide-independent relaxations to acetylcholine and A23187 involve different routes of heterocellular communication. Role of Gap junctions and phos-pholipase A2. Circ Res 84: 53-63, 1999.
11. Ischia R, Gasser RW, Fischer-Colbrie R, Eder U, Pagani A, Cubeddu LX, Lovisetti-Scamihorn P, Finkenstedt G, Laslop A, Winkler H. Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients. J Clin Endocrinol Metab 85: 355-360, 2000.
12. Kahler CM, Kaufmann G, Kahler ST, Wiedermann CJ. The neuro-peptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro. Regul Pept 110: 65-73, 2002.
13. Kahler CM, Schratzberger P, Kaufmann G, Hochleitner B, Bechter O, Gotsch C, Woll E, Marschang P, Herold M, Wiedermann CJ. Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin. Regul Pept 105: 35-46, 2002.
14. Kirchmair R, Egger M, Walter DH, Eisterer W, Niederwanger A, Woell E, Nagl M, Pedrini M, Murayama T, Frauscher S, Hanley A, Silver M, Brodmann M, Sturm W, Fischer-Colbrie R, Losordo DW, Patsch JR, Schratzberger P. Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation 110: 1121-1127, 2004.
15. Kirchmair R, Gander R, Egger M, Hanley A, Silver M, Ritsch A, Murayama T, Kaneider N, Sturm W, Kearny M, Fischer-Colbrie R, Kircher B, Gaenzer H, Wiedermann CJ, Ropper AH, Losordo DW, Patsch JR, Schratzberger P. The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation 109: 777-783, 2004.
16. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci 17: 399-402, 1992.
17. Lee MY, Tse HF, Siu CW, Zhu SG, Man RY, Vanhoutte PM. Genomic changes in regenerated porcine coronary arterial endothelial cells. Arte-rioscler Thromb Vasc Biol 27: 2443-2449, 2007.
18. Lee MY, Wang Y, Vanhoutte PM. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFkappaB. J Vasc Res 47: 287-298, 2009.
19. Leitner B, Schneitler C, Klocker H, Volknandt W, Zimmermann H, Winkler H, Fischer-Colbrie R. Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin II, in mammalian, bird, reptile, amphibian and fish brains. Neurosci Lett 248: 105-108, 1998.
20. Mombouli JV, Illiano S, Vanhoutte PM. Local production of kinins contributes to the endothelium dependent relaxations evoked by converting enzyme inhibitors in isolated arteries. Agents Actions Suppl 38: 186-195, 1992.
21. Mombouli JV, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol 117: 413-418, 1996.
22. Moncada S, Vane JR. Pharmacology and endogenous roles of prosta-glandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30: 293-331, 1978.
23. Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192: 309-324, 2008.
24. Nagao T, Illiano S, Vanhoutte PM. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br J Pharmacol 107: 382-386, 1992.
25. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endotheli-um-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 92: 2867-2871, 1993.
26. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
27. Shibano T, Codina J, Birnbaumer L, Vanhoutte PM. Pertussis toxin-sensitive G proteins in regenerated endothelial cells of porcine coronary artery. Am J Physiol Heart Circ Physiol 267: H979-H981, 1994.
28. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 83: 652-660, 1991.
29. Stridsberg M, Eriksson B, Janson ET. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours. Regul Pept 148: 95-98, 2008.
30. Strijdom H, Chamane N, Lochner A. Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr 20: 303-310, 2009.
31. Tang EH, Feletou M, Huang Y, Man RY, Vanhoutte PM. Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-medi-ated contractions. Am J Physiol Heart Circ Physiol 289: H2434-H2440, 2005.
32. _/_ knockout mice. J Cardiovasc Pharmacol 46: 761-765, 2005.
33. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogra-nin family. N Engl J Med 348: 1134-1149, 2003.
34. Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J 73: 595-601, 2009.
35. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222, 2009.
36. Yan S, Wang X, Chai H, Wang H, Yao Q, Chen C. Secretoneurin increases monolayer permeability in human coronary artery endothelial cells. Surgery 140: 243-251, 2006.
37. Zhao E, Zhang D, Basak A, Trudeau VL. New insights into granin-derived peptides: evolution and endocrine roles. Gen Comp Endocrinol 164: 161-174, 2009.